Today's Research: Delcath Systems, Astex Pharma, BioMarin Pharma, and Akorn

 Today's Research: Delcath Systems, Astex Pharma, BioMarin Pharma, and Akorn

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

LONDON, July 18, 2013

LONDON, July 18, 2013 /PRNewswire/ --

On Wednesday, July 17, 2013, shares in the healthcare sector ended mostly
lower even as the broader market ended higher following positive news from
Federal Reserve Chairman Ben Bernanke. The major movers in the sector included
Delcath Systems Inc. (NASDAQ: DCTH), Astex Pharmaceuticals Inc. (NASDAQ:
ASTX), BioMarin Pharmaceuticals Inc. (NASDAQ: BMRN), and Akorn Inc. (NASDAQ:
AKRX). AAAResearchReports.com has completed their technical analysis on DCTH,
ASTX, BMRN, and AKRX and these free reports are accessible by registering at:

http://www.aaaresearchreports.com/register/ 

Shares in Delcath Systems Inc. moved lower on Wednesday, extending their
losses for the week. The company's shares ended the day at $0.377, down 0.79%,
after oscillating between $0.36 and $0.38. A total of 717,445 shares were
traded which is less than its daily average volume of 1.61 million. In the
last three months, Delcath's shares have fallen by 73.07% as compared to a
gain of 8.31% in the S&P 500. Sign up for free technical research on DCTH at:

http://www.AAAResearchReports.com/DCTH071813.pdf

Astex Pharmaceuticals Inc.'s stock rose sharply on Wednesday, extending their
gains for the week. The company's shares fluctuated between $5.48 and $5.70
before finishing the day 2.93% higher at $5.63. A total of 1.24 million shares
were traded which is below the daily average volume of 1.57 million. Astex's
shares have now gained 15.37% in the last one month, thus outperforming the
S&P 500. However, in the last three months, the stock has fallen by 9.49%. Be
sure to read our latest technical research on ASTX by registering at:

http://www.AAAResearchReports.com/ASTX071813.pdf

Shares in BioMarin Pharmaceuticals Inc. edged lower on Wednesday even as the
broader market ended higher. The company's shares oscillated between $62.42
and $63.39 before closing the session 0.30% lower at $62.64. A total of
566,476 shares were traded which is less than its daily average volume of 1.38
million. The company's shares have gained 7.68% in the last one month as
compared to a gain of 2.55% in the S&P 500. The stock has fallen by 3.35% and
1.63% in the last three trading sessions and the last three months,
respectively, thus underperforming the S&P 500. Sign up and read the
complimentary report on BMRN at:

http://www.AAAResearchReports.com/BMRN071813.pdf

Akorn Inc.'s stock closed 4.07% lower on Wednesday at $13.43 after fluctuating
between $13.40 and $14.05. A total of 544,543 shares were traded which is
slightly above the daily average volume of 541,382. The company's shares have
fallen by 0.67% in the last one month, and 5.95% in the last three months,
thus underperforming the S&P 500. The free report on AKRX can be downloaded by
signing up now at:

http://www.AAAResearchReports.com/AKRX071813.pdf

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
    below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

SOURCE AAA Research Reports

Contact: AAAresearchreports.com Phone #: +1(646)396-9126